Triumeq 600-50-300 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJR17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,258
Award facts
- Contract value 100% obligated
- $23,257.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,257.91 to AmerisourceBergen Drug Corp for 30-unit supplies of TRIUMEQ 600-50-300 mg tablets. This contract is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company's extensive portfolio under its DLA contract encompasses a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for TRIUMEQ—a combination antiretroviral medication—supports the Defense Health Agency and other federal healthcare systems' pharmaceutical supply requirements. The contract award demonstrates AmerisourceBergen's established capability to meet federal procurement standards through the DLA's global pharmaceutical prime vendor vehicle, which is designed to enable flexible and comprehensive medical supply support to military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FJR17?
SPE2DB25FJR17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FJR17 worth?
The government has obligated $23,258 on SPE2DB25FJR17.
Is contract SPE2DB25FJR17 an order under another contract?
Yes. SPE2DB25FJR17 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJR17 competed?
The extent of competition for SPE2DB25FJR17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award